Product
Sulfonylurea
6 clinical trials
10 indications
Indication
Type 2 Diabetes MellitusIndication
Type 2 DiabetesIndication
Cardiac DiseaseIndication
DiabetesIndication
Neurodevelopmental DisordersIndication
Intellectual disabilityIndication
Developmental DelayIndication
ADHDIndication
Autism Spectrum DisorderIndication
EpilepsyClinical trial
Harmonizing RCT-Duplicate Emulations: A Real World Replication Program Analyzing Three Clinical Trials, CANVAS, LEADER, and SAVOR TIMI in Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2023-08-31
Clinical trial
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease RiskStatus: Active (not recruiting), Estimated PCD: 2025-04-01
Clinical trial
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare ClaimsStatus: Completed, Estimated PCD: 2021-02-18
Clinical trial
Replication of the TECOS Diabetes Trial in Healthcare ClaimsStatus: Completed, Estimated PCD: 2021-02-18
Clinical trial
Impact of Timing of Initiation of Sulphonylurea Therapy on Neurodevelopmental Outcomes in Individuals With Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome Due to the V59M Mutation in the KCNJ11 GeneStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Replication of the CARMELINA Diabetes Trial in Healthcare ClaimsStatus: Completed, Estimated PCD: 2021-02-18